Просмотр новости

Найдите то, что Вас интересует

Bioinformatics-based Investigation to Unveiling The miRNA-Immunity Axis in The Tumor Microenvironment of Pancreatic Cancer [version 3; peer review: 2 approved, 1 not approved]

Дата публикации: 22-05-2026 16:20:24

Background In this Bioinformatics study, we took in account the cell types variation of tumor microenvironment (TME) in Pancreatic Ductal Adenocarcinoma (PDAC), with a particular attention to miRNAs dysregulated pathways influencing immune responses, and especially memory CD4+ T cells. Methods For cell types and differentially expressed genes in memory CD4+ T cells, scRNA-seq was conducted on PDAC and non-tumoral pancreas samples. Putative miRNA targeting sequences on downregulated genes were investigated by three prediction databases, MiRWalk, TargetScan, and miRDB, and compared to GSE207345’s differential expression with creation of Affymetrix Multispecies miRNA-4 Array. The miRNA–mRNA interaction network was established in Cytoscape. Results Memory CD4+ T cells were significantly enriched in PDAC TME. At the same time, we observed genotype-specific repression of major immune and metabolic genes in these cells. Some miRNAs were significantly overexpressed in PDAC, and hsa-miR-1207-5p, hsa-miR-6805-5p, and hsa-miR-149-3p might target many immune-related or pancreatic enzyme-associated genes. Of these, a core of CLPS, NR4A2, and SOCS3 was most frequently targeted, which likely indicated the importance of these genes in immune evasion. Conclusions While memory CD4+ T cells exist within the PDAC TME, their activity is suppressed by miRNA-associated gene dysregulation. These data suggest candidate therapeutic approaches in which targeting of miRNAs could be used to normalize immune cells and promote anti-tumor immunity.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Un hospital identifica una nueva estrategia contra el cáncer de páncreas que ataca las células tumorales y activa el sistema inmunitario7819-06-2026
2Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy0018-06-2026
3Error in Open Access License0018-06-2026
4دواء تجريبي يعزز فرص النجاة لدى مرضى سرطان البنكرياس0031-05-2026
5Diagnostic Performance of Computed Tomography-Based Machine Learning Models in the Classification of Adnexal Masses - A Systematic Review [version 1; peer review: 2 approved]0702-04-2026
6Development of a machine learning predictive model for early detection of breast cancer [version 6; peer review: 1 approved, 2 approved with reservations, 2 not approved]0523-06-2026
7Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer0018-06-2026
8Artificial Intelligence–Based Risk Prediction Models for Complications After Tongue Cancer Surgery0018-06-2026
9Российские ученые выявили новые мутации, которые провоцируют опухоли поджелудочной железы0030-09-2019
10Pandemic disruptions to health care worsened cancer survival, study suggests0005-02-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: f1000research.com.